易明医药 (002826.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 3.25B

MomentumView details →

1D Return

−1.56%

YTD Return

−3.65%

RSI (14)

55.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 3.25B

RSI (14)

55.0

MomentumView details →

1D Return

−1.56%

YTD Return

−3.65%

ProfitabilityView details →

Gross Margin

82.71%

Net Margin

13.94%

EBITDA Margin

17.86%

ROE (TTM)

11.15%

ROA (TTM)

8.47%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

+4.74%

EPS YoY

+158.25%

FCF YoY

+103.00%

Revenue CAGR 3Y

−9.44%

EPS CAGR 3Y

+29.54%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

2.78x

Quick Ratio

2.56x

Div Yield

0.85%

Div Rate

CNY 0.15

Div Growth 1Y

+50.00%

Financials snapshotView financials →

Revenue (TTM)

670.32M

Net Income (TTM)

93.44M

Op. CF (TTM)

172.22M

Latest newsMore news →

Yiming Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 66.6797 million yuan, up 77.54% year-on-year.10d ago

Similar companies

中创环保300056.SZ 摩恩电气002451.SZ 万年青000789.SZ 安凯客车000868.SZ 帝欧水华002798.SZ 双飞集团300817.SZ Find similar companies →

Latest newsMore news →

Yiming Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 66.6797 million yuan, up 77.54% year-on-year.10d ago